CIK 0001274737 · Non-accelerated filer<br>Smaller reporting company
EXAGEN INC.
Sign in to watch- Ticker
- XGN
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (760) 560-1501
- Business address
- 1261 LIBERTY WAY, VISTA, CA, 92081
- Former names
- EXAGEN DIAGNOSTICS INC
- Open-market buys, last 90 days
- $568,660
- in 3 filings
- Open-market sales, last 90 days
- $1,233,534
- in 4 filings
Net −$664,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-17 | Robertson Bruce C Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2021-06-17 | Nova Tina Susan Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2021-06-17 | Johnson Wendy S. Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2021-06-17 | Birk Brian Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2021-06-17 | TULLIS JAMES L L Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2021-05-17 | Hazeltine Mark Chief Operating Officer | Option exercise | +1,934 | $0.26 | $503 | 39,434 |
| 2021-05-17 | Hazeltine Mark Chief Operating Officer | Option exercise · Stock Option(right to buy) | −1,934 | $0.26 | $503 | 1,061 |
| 2021-02-23 | Adawi Kamal Chief Financial Officer | Grant or award | +37,500 | 37,500 | ||
| 2021-02-23 | Adawi Kamal Chief Financial Officer | Grant or award · Stock Option(right to buy) | +12,500 | 12,500 | ||
| 2021-02-23 | Zack Debra Chief Medical Officer | Grant or award | +37,500 | 37,500 | ||
| 2021-02-23 | Zack Debra Chief Medical Officer | Grant or award · Stock Option(right to buy) | +12,500 | 12,500 | ||
| 2021-02-23 | Rocca Fortunato R. President and CEO | Grant or award | +50,000 | 50,000 | ||
| 2021-02-23 | Rocca Fortunato R. President and CEO | Grant or award · Stock Option(right to buy) | +40,000 | 40,000 | ||
| 2021-02-05 | TULLIS JAMES L L Director | Sale | −3,000 | $17.00 | $51K | 21,348 |
| 2021-01-25 | Hunt Holdings Limited Partnership 10% owner | Sale | −28,021 | $16.01 | $449K | 1,261,324 |
| 2021-01-22 | Hunt Holdings Limited Partnership 10% owner | Sale | −23,646 | $16.07 | $380K | 1,289,345 |
| 2021-01-21 | Hunt Holdings Limited Partnership 10% owner | Sale | −50,000 | $16.01 | $801K | 1,312,991 |
| 2021-01-20 | Hunt Holdings Limited Partnership 10% owner | Sale | −30,000 | $16.13 | $484K | 1,362,991 |
| 2021-01-19 | Hunt Holdings Limited Partnership 10% owner | Sale | −30,000 | $16.00 | $480K | 1,392,991 |
| 2021-01-19 | TULLIS JAMES L L Director | Sale | −257 | $15.56 | $4K | 24,348 |
Page 6 of 7 · 128 trades